Table 3 Relationship between the type of procedure for additional indications and NHI price revisions
Without NHI price revision | With NHI price revision | Total | P-value* | |||
|---|---|---|---|---|---|---|
Without additional indication | 41 | 83.7% | 8 | 16.3% | 49 | <0.001 |
Type A (Expansion) | 7 | 36.8% | 12 | 63.2% | 19 | |
Type B (Retention) | 8 | 88.9% | 1 | 11.1% | 9 | |
Type C (Targeting small cancer) | 2 | 50.0% | 2 | 50.0% | 4 | |
Total | 58 | 71.6% | 23 | 28.4% | 81 | |